These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37024305)

  • 1. Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models.
    Jallinoja VIJ; Abbriano CH; Bhatt K; Kaur A; Schlyer DJ; Yazaki PJ; Carney BD; Houghton JL
    J Nucl Med; 2023 Aug; 64(8):1203-1209. PubMed ID: 37024305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Copper-64-Based Host-Guest Chemistry Pretargeted Positron Emission Tomography.
    Jallinoja VIJ; Carney BD; Bhatt K; Abbriano CH; Schlyer DJ; Yazaki PJ; Houghton JL
    Mol Pharm; 2022 Jul; 19(7):2268-2278. PubMed ID: 35700402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cucurbituril-Ferrocene: Host-Guest Based Pretargeted Positron Emission Tomography in a Xenograft Model.
    Jallinoja VIJ; Carney BD; Zhu M; Bhatt K; Yazaki PJ; Houghton JL
    Bioconjug Chem; 2021 Aug; 32(8):1554-1558. PubMed ID: 34156824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PET.
    Strebl MG; Yang J; Isaacs L; Hooker JM
    Mol Imaging; 2018; 17():1536012118799838. PubMed ID: 30354934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
    J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-Assisted Host-Guest Interactions Revealed by Single-Molecule Force Spectroscopy.
    Pandey S; Kankanamalage DVDW; Zhou X; Hu C; Isaacs L; Jayawickramarajah J; Mao H
    J Am Chem Soc; 2019 Nov; 141(46):18385-18389. PubMed ID: 31679339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
    Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
    Patil V; Gada K; Panwar R; Varvarigou A; Majewski S; Weisenberger A; Ferris C; Tekabe Y; Khaw BA
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-In-Human Pilot PET Immunoimaging Study of
    Wong JYC; Yamauchi DM; Adhikarla V; Simpson J; Frankel PH; Fong Y; Melstrom KA; Chen YJ; Salehian BD; Woo Y; Dandapani SV; Colcher DM; Poku EK; Yazaki PJ; Wu AM; Shively JE
    Cancer Biother Radiopharm; 2023 Feb; 38(1):26-37. PubMed ID: 36154291
    [No Abstract]   [Full Text] [Related]  

  • 13. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
    Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
    Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
    J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with
    Zhang Y; Lin Q; Wang T; Shi D; Fu Z; Si Z; Xu Z; Cheng Y; Shi H; Cheng D
    Mol Pharm; 2022 Jan; 19(1):246-257. PubMed ID: 34816721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas-phase fragmentation of 1-adamantylbisimidazolium salts and their complexes with cucurbit[7]uril studied using selectively
    Čablová A; Rouchal M; Hanulíková B; Vícha J; Dastychová L; Prucková Z; Vícha R
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1510-1518. PubMed ID: 28590526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
    Griffiths GL; Chang CH; McBride WJ; Rossi EA; Sheerin A; Tejada GR; Karacay H; Sharkey RM; Horak ID; Hansen HJ; Goldenberg DM
    J Nucl Med; 2004 Jan; 45(1):30-9. PubMed ID: 14734668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.